MIDAS PHARMA GMBH
Germany
Doxazosin Mesylate
Doxazosin Mesylate; Active Pharmaceutical Ingredient; EP; CAS 77883-43-3
Description
Doxazosin Mesylate is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads 77883-43-3. It is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia - BPH. Doxazosin mesylate is a selective α-blocker that selectively binds to α1-receptors, thus dilating peripheral blood vessels. This reduces blood pressure and cholesterol levels of the serum. Detailed specification, Certificate of Analysis and samples are available on request.
Pharmaceutical products
- API
- antihypertensive
- Doxazosin Mesylate
Product features
CAS | 77883-43-3 |
Product Information | API |
Route of Synthesis | Synthetic |
Patent Expiry | EU, US - expired |
Indication | Antihypertensive, Adrenergic Blocker |
Dosage | Oral formulation |
View this product on the company site
Doxazosin Mesylate
Other products from this business
More information on the company's website
http://ky.to/www.midas-pharma....